Hot Stocks

Hot stocks are not about hype. They emerge when powerful themes, policy shifts, and capital flows converge. InvestorPlace analysts track fast-moving market narratives, especially in technology, AI, and infrastructure, to identify stocks drawing outsized attention and explain what is really driving those moves.

Investor Interest in All Things Alternative Fuel-ing PLUG Stock Higher

The rally in PLUG stock may have more legs as investor enthusiasm for everything related to hydrogen and fuel cells continues.

Here’s Why You Should Consider an Exit Plan from Marathon Oil Stock

Think oil's coming back? A gamble on MRO stock makes sense. But fundamentals are getting uglier by the day, Marathon is unpalatable to all but the most extreme speculators.

Apple Still Looks Expensive But iPhone Launch Could Push It Higher

AAPL stock looks somewhat expensive here but Apple's new 5G iPhone launch could be a catalyst.Keep a close eye on it.

Top-Line Growth Will Keep Fastly Stock in the Fast Lane

A higher customer count, raised fiscal guidance and outstanding revenue expansion all contribute to the bull case for FSLY stock.

JinkoSolar News: JKS Stock Jumps 8% on Vietnam Project

JinkoSolar (JKS) news for Monday concerning a massive solar power project with Trung Nam in Vietnam has JKS stock lighting up.

The Kensington Capital Merger With QuantumScape Will Be a Winner

Kensington Capital stock could push at least 50% higher after the merger if QuantumScape's lithium metal technology pans out.

Groupon News: Why GRPN Stock Is Sliding 12% Lower Today

Groupon (GRPN) stock is falling on Monday after providing an update about its business on Friday that investors aren't happy with.

CenturyLink Name Change: Say Hello to Lumen Technologies

CenturyLink is ditching its old name in favor of a change to Lumen Technologies as it looks to prepare for the fourth industrial revolution.

Scientific Games News: Why SGMS Stock Is Soaring 37% Today

Scientific Games (SGMS) is in the news Monday as a change to its investors and the Board of Directors boosts SGMS stock higher.

Immunomedics News: IMMU Stock Skyrockets 99% on Gilead Deal

Immunomedics (IMMU) is seeing IMMU stock soar higher Monday following news that it will be acquired by Gilead (GILD) for $21 billion.

Oracle-TikTok Deal: 11 Things for ORCL Stock Investors to Know

Oracle (ORCL) is moving forward with plans to buy Chinese social media app TikTok and we have a few things to know about the deal.

Nikola’s Troubles With Short Sellers Raise Questions About Its Value

NKLA stock could lose more value depending on the official terms of its agreement with GM. It may be wisest to wait.

Fastly Could Sink in the Near-Term

Although Fastly has become a crucial tool in a socially-distanced world, FSLY stock is likely to stay under pressure in the coming weeks.

VXRT Stock: Vaxart Shoots Higher on Human Trial Approval

Vaxart just announced it will begin enrolling participants in human trials of its coronavirus vaccine. VXRT stock is popping in response.

If Load Factors Matter, JetBlue Airways Is in Trouble

With coronavirus cases declining and JetBlue adding more flights, the bullish narrative for JBLU stock appears enticing. However, the underlying company has not performed well relative to its competitors.

The Ultimate EV Investing Guide: 23 Electric Car Stocks to Watch

This all-encompassing guide to electric car stocks will teach you everything you need to know to profit from the booming market trend.

7 Coronavirus Vaccine Stocks to Watch as Approval Nears

Whether or not we get an 'October Surprise' from President Donald Trump, these coronavirus vaccine stocks look hot now. AstraZeneca (NYSE:AZN) CureVac (NASDAQ:CVAC) GlaxoSmithKline (NYSE:GSK) Inovio (NASDAQ:INO) Johnson & Johnson (NYSE:JNJ) Moderna (NASDAQ:MRNA) Novavax (NASDAQ:NVAX)

Will Nikola Stock Continue to Benefit From GM Partnership Announcement?

Nikola stock is likely to be volatile before it finds new and stable roads for revenue growth

Novavax Stock Has a Clear Path to Over $200

Novavax is likely to recover with its vaccine results. If successful, I think its vaccine will make NVAX stock worth at least $229.